CHMP is reviewing avacopan, a drug authorized in the EU for treating adults with severe, active granulomatosis with polyangiitis or microscopic polyangiitis.

"EMA will now review all available data to assess whether this emerging information has an impact on the balance of benefits and risks of Tavneos," said the EU regulator. "The agency will then issue a ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Microscopic Polyangiitis (MPA) - Pipeline Review, H1 2017" report to their offering. Pharmaceutical and Healthcare ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with granulomatosis with polyangiitis and microscopic polyangiitis who lower their ...

The prophylactic efficacy of TMP-SMX was significantly higher in subgroups with baseline lymphopenia, azotemia, microscopic polyangiitis, or relapsed AAV. Prophylactic use of ...

Please provide your email address to receive an email when new articles are posted on . New Pan American League of Associations for Rheumatology recommendations include remission maintenance ...